Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva-Maria Mandelkow

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|October 27, 2020
A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modificationsFriedel Drepper, Jacek Biernat, Senthilvelrajan Kaniyappan, et al.
Biochemistry|August 10, 2007
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cellsMarcus Pickhardt, Gregor Larbig, Inna Khlistunova, et al.
The Journal of Biological Chemistry|May 25, 2017
Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architectureHans Zempel, Frank J A Dennissen, Yatender Kumar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 30, 2008
Accurate balance of the polarity kinase MARK2/Par-1 is required for proper cortical neuronal migrationTamar Sapir, Sivan Sapoznik, Talia Levy, et al.
Molecular Biology of the Cell|November 14, 2002
Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarityJacek Biernat, Yong-Zhong Wu, Thomas Timm, et al.
Brain Structure & Function|June 4, 2014
Molecular imaging reveals epileptogenic Ca2+-channel promoter activation in hippocampi of living miceRebecca Kulbida, Yipeng Wang, Eva-Maria Mandelkow, et al.
EMBO Reports|March 3, 2016
The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicityJochen Martin Decker, Lars Krüger, Astrid Sydow, et al.
Molecular Neurobiology|September 10, 2018
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau FragmentGhulam Jeelani Pir, Bikash Choudhary, Senthilvelrajan Kaniyappan, et al.
The Journal of Biological Chemistry|October 26, 2005
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugsInna Khlistunova, Jacek Biernat, Yipeng Wang, et al.
Molecular Biology of the Cell|July 15, 2005
PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actinDorthe Matenia, Bettina Griesshaber, Xiao-yu Li, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|October 27, 2020
A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modificationsFriedel Drepper, Jacek Biernat, Senthilvelrajan Kaniyappan, et al.
Biochemistry|August 10, 2007
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cellsMarcus Pickhardt, Gregor Larbig, Inna Khlistunova, et al.
The Journal of Biological Chemistry|May 25, 2017
Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architectureHans Zempel, Frank J A Dennissen, Yatender Kumar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 30, 2008
Accurate balance of the polarity kinase MARK2/Par-1 is required for proper cortical neuronal migrationTamar Sapir, Sivan Sapoznik, Talia Levy, et al.
Molecular Biology of the Cell|November 14, 2002
Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarityJacek Biernat, Yong-Zhong Wu, Thomas Timm, et al.
Brain Structure & Function|June 4, 2014
Molecular imaging reveals epileptogenic Ca2+-channel promoter activation in hippocampi of living miceRebecca Kulbida, Yipeng Wang, Eva-Maria Mandelkow, et al.
EMBO Reports|March 3, 2016
The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicityJochen Martin Decker, Lars Krüger, Astrid Sydow, et al.
Molecular Neurobiology|September 10, 2018
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau FragmentGhulam Jeelani Pir, Bikash Choudhary, Senthilvelrajan Kaniyappan, et al.
The Journal of Biological Chemistry|October 26, 2005
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugsInna Khlistunova, Jacek Biernat, Yipeng Wang, et al.
Molecular Biology of the Cell|July 15, 2005
PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actinDorthe Matenia, Bettina Griesshaber, Xiao-yu Li, et al.
Pageof 12